Combined Immunodeficiency

Gene: CIITA

Green List (high evidence)

CIITA (class II major histocompatibility complex transactivator)
EnsemblGeneIds (GRCh38): ENSG00000179583
EnsemblGeneIds (GRCh37): ENSG00000179583
OMIM: 600005, Gene2Phenotype
CIITA is in 6 panels

1 review

Danielle Ariti (University of Melbourne)

Green List (high evidence)

13 individuals of 11 unrelated families; two mouse models

Homozygous and compound heterozygous variants were identified in these individuals (missense, nonsense and splicing) resulting in premature stop codon and truncated protein, or inactive protein.

Affected individuals typically present with sever (recurrent) respiratory and gastrointestinal tract infections and defective MHC II expression in PBMCs.
Created: 22 Jul 2021, 5:03 a.m. | Last Modified: 22 Jul 2021, 5:03 a.m.
Panel Version: 0.216

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Bare Lymphocyte Syndrome, type II, complementation group A MIM# 209920; varied ID; bronchiolitis; pneumonia; severe autoimmune cytopaenia; CD4 T-cell lymphopaenia; hypogammaglobulinemia; absence of antigen-induced immune response; chronic diarrhoea; recurrent respiratory infections; recurrent gastroenteritis; failure to thrive; liver/biliary tract disease

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Melbourne Genomics Health Alliance Immunology Flagship
  • Victorian Clinical Genetics Services
Phenotypes
  • Bare Lymphocyte Syndrome, type II, complementation group A MIM# 209920
  • varied ID
  • bronchiolitis
  • pneumonia
  • severe autoimmune cytopaenia
  • CD4 T-cell lymphopaenia
  • hypogammaglobulinemia
  • absence of antigen-induced immune response
  • chronic diarrhoea
  • recurrent respiratory infections
  • recurrent gastroenteritis
  • failure to thrive
  • liver/biliary tract disease
OMIM
600005
Clinvar variants
Variants in CIITA
Penetrance
None
Publications
Panels with this gene

History Filter Activity

22 Jul 2021, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: ciita has been classified as Green List (High Evidence).

22 Jul 2021, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: CIITA were changed from to Bare Lymphocyte Syndrome, type II, complementation group A MIM# 209920; varied ID; bronchiolitis; pneumonia; severe autoimmune cytopaenia; CD4 T-cell lymphopaenia; hypogammaglobulinemia; absence of antigen-induced immune response; chronic diarrhoea; recurrent respiratory infections; recurrent gastroenteritis; failure to thrive; liver/biliary tract disease

22 Jul 2021, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: CIITA were set to

22 Jul 2021, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: CIITA was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: CIITA was added gene: CIITA was added to Combined immunodeficiency_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: CIITA was set to Unknown